[CLSTR]
API
< Back to situations

[ORGANIZATION]

Gilead Sciences

Featured in 37 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [DE] [US]

Mayo Clinic pancreatic cancer vaccine clinical trial

3 clusters · 10 sources · last updated

Latest: BioNTech and Camupepimut report clinical trial results for cancer treatments

Researchers at Mayo Clinic have reported promising results from a phase 2 clinical trial of an investigational, ‘off the shelf’ vaccine designed to target KRAS mutations in pancreatic ductal adenocarcinoma. The study, pu

[ACTIVE] [HEALTH] [BR] [UG] [US]

Lenacapavir HIV prevention rollout and generic approval

13 clusters · 124 sources · last updated

Latest: FDA approves generic lenacapavir for HIV prevention

Lenacapavir, a long-acting injectable medication for HIV pre-exposure prophylaxis (PrEP), has demonstrated high efficacy in clinical trials, reducing the risk of HIV transmission by 99.9%. The drug, which requires only t

[ACTIVE] [BUSINESS] [US]

Pharmaceutical industry market trends

2 clusters · 2 sources · last updated

Latest: Goldman Sachs analysts maintain bullish outlook on pharmaceutical sector

Major pharmaceutical companies, including AbbVie, Eli Lilly, and Gilead Sciences, have seen stock prices reach or approach record highs. This movement reflects a shift in investor capital from high-risk technology growth

[ACTIVE] [HEALTH] [CD] [UG] [US]

DRC Ebola outbreak expands and impacts healthcare workers

439 clusters · 3350 sources · last updated

Latest: Belgium deploys mobile laboratory to Congo to combat Ebola outbreak

The Bundibugyo-strain Ebola outbreak in the Democratic Republic of Congo (DRC) continues to escalate, marking one of the deadliest epidemics in the country’s history. As of late October 2026, confirmed cases have surpass

[QUIET] [HEALTH] [IT]

Art and storytelling in Rome cancer care

2 clusters · 19 sources · last updated

Latest: Rome hospital integrates art into cancer radiotherapy treatment

Healthcare initiatives in Rome are increasingly incorporating art and personal narratives to support cancer patients. At the Policlinico Universitario Agostino Gemelli, a photography exhibition titled ‘Da qui in avanti.

[QUIET] [HEALTH] [KR] [US]

GC Cell advances GCC2005 CAR-NK therapy development

4 clusters · 6 sources · last updated

Latest: GC Cell begins Phase 1b clinical trials for GCC2005

GC Cell is advancing its GCC2005 CAR-NK cell therapy, a CD5-targeted allogeneic treatment for refractory T-cell lymphoma. The company has partnered with QuantHealth to use AI-based clinical trial simulations to optimize

Also covered in